The Suspect in the J6 Pipe Bombing Incident Has Been Captured. Why the...
A Newsom Nihilist Nomination?
The Importance of Being Earnest
Media Make 'Venezuelan Fishermen' the New 'Maryland Father,' and Covering Up the Minnesota...
New Mexico Democrats Push Bill Based on Results of Idiotic Study
Israeli Prime Minister Says He'll Happily Visit NYC Despite Mamdani's Threat to Uphold...
Climate Study That Shaped Global Policy Retracted After Major Error
Inside a Secret Transgender Health Conference: Clinicians Admit They're All Just 'Winging...
U.S. Secret Service Seized 16 Illegal Skimmers, Stopped $16M in Fraud
Two Men Charged After 1,585 Pounds of Meth Found Hidden in Blackberry Shipments...
SCOTUS Upholds New Texas Redistricting Map
Georgia CEO Gets Eight Years for Bribery Scheme Involving Honduran Police Contracts
Appeals Court Grants Administrative Stay to Keep National Guard in D.C.
Santa Monica Doctor Gets 30 Months for Illegally Supplying Ketamine to Actor Matthew...
The Day a Mall Became a Stage for a Hate Movement
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement